O'Callaghan Jeremiah Alphonsus 4

What Happened
Jeremiah O'Callaghan, a director of JBS N.V. (JBS), was granted two equity awards on May 21, 2026 totaling 76,782 restricted stock units (RSUs): 49,554 RSUs and 27,228 RSUs. These awards are reported as grants (transaction code A) and are derivative awards (no purchase price reported). The filing does not state an immediate cash value; the RSUs represent the contingent right to receive one Class A common share (or one Brazilian Depositary Receipt) per RSU upon vesting.

Key Details

• Transaction date: May 21, 2026 (Form 4 filed May 22, 2026).
• Award amounts: 49,554 RSUs and 27,228 RSUs (total 76,782 RSUs).
• Prices/values: N/A in the Form 4 (RSUs — no purchase price).
• Vesting: 49,554 RSUs vest pro rata on Mar 1, 2027; Mar 1, 2028; Mar 1, 2029. 27,228 RSUs vest pro rata on Aug 1, 2026; Aug 1, 2027; Aug 1, 2028.
• Each RSU = contingent right to one Class A common share or one BDR (Brazilian Depositary Receipt).
• Shares owned after the transaction: not specified in the provided filing.
• Regulatory note: Because JBS is a foreign private issuer, these transactions are exempt from Sections 16(b) and 16(c) of the Exchange Act (per the filing remarks).
• Filing timeliness: Report appears timely (transaction on 2026-05-21; Form 4 filed 2026-05-22).

Context
RSU grants are a form of compensation that convert into actual shares (or BDRs) only when they vest; they are not an immediate market purchase or sale. Such awards are routine for executives and directors and do not by themselves signal a buy/sell decision — their future value depends on JBS’s share/BDR price at vesting.